A detailed history of Entropy Technologies, LP transactions in United Therapeutics Corp stock. As of the latest transaction made, Entropy Technologies, LP holds 1,683 shares of UTHR stock, worth $604,550. This represents 0.06% of its overall portfolio holdings.

Number of Shares
1,683
Previous 2,980 43.52%
Holding current value
$604,550
Previous $949 Million 36.47%
% of portfolio
0.06%
Previous 0.1%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$311.04 - $363.55 $403,418 - $471,524
-1,297 Reduced 43.52%
1,683 $603 Million
Q2 2024

Aug 12, 2024

BUY
$228.26 - $319.04 $680,214 - $950,739
2,980 New
2,980 $949 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.3B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Entropy Technologies, LP Portfolio

Follow Entropy Technologies, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Entropy Technologies, LP, based on Form 13F filings with the SEC.

News

Stay updated on Entropy Technologies, LP with notifications on news.